# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-13-157712
Filing Date
2013-04-17
Accepted
2013-04-17 06:25:33
Documents
9
Period of Report
2013-04-17

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | d523131d6k.htm | 6-K | 30938
2 | GRAPHIC | g523131g25d46.jpg | GRAPHIC | 233870
3 | GRAPHIC | g523131g30a67.jpg | GRAPHIC | 9000
4 | GRAPHIC | g523131g31u03.jpg | GRAPHIC | 318151
5 | GRAPHIC | g523131g50b16.jpg | GRAPHIC | 359985
6 | GRAPHIC | g523131g60e10.jpg | GRAPHIC | 345586
7 | GRAPHIC | g523131g66n33.jpg | GRAPHIC | 134794
8 | GRAPHIC | g523131img010.jpg | GRAPHIC | 211057
9 | GRAPHIC | g523131img011.jpg | GRAPHIC | 302948
| Complete submission text file | 0001193125-13-157712.txt |  | 2672101

Mailing Address LEVEL 1 1 - 7 WATERLOO ROAD NORTH RYDE NSW C3 2113
Business Address LEVEL 1 1 - 7 WATERLOO ROAD NORTH RYDE NSW C3 2113 01161298780088
NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 13765723
SIC: 2834 Pharmaceutical Preparations